$8.690
+0.020 (+0.23%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de DMAC por análisis de gráficos similares
Alphio's DMAC stock price prediction model matches the current DiaMedica Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $8.63 (+0.01%). The 1-week path is $8.17 (-5.34%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de DiaMedica Therapeutics Inc?
DiaMedica Therapeutics Inc (DMAC) is currently priced at $7.57, which is near its 200-day simple moving average of $7.081, indicating potential support. However, the stock has a low RSI of 37.218, suggesting it is oversold, yet it has also experienced a significant 9.12% drop over the past five days. The company's forward P/E ratio is 0, indicating no earnings expected in the near term, which raises concerns about its profitability. The main risk is the widening net loss reported for Q2 2026, which reached $10.1 million, up from $7.7 million the previous year, highlighting ongoing financial challenges.
DMAC cerró en $8.69 el Wednesday, tras subir +0.23%
DiaMedica Therapeutics Inc (DMAC) last closed at $8.63, losing -0.69%. These facts feed the 1-day and 1-week DMAC price prediction above.
Factores de la previsión
Los factores de la previsión de DiaMedica Therapeutics Inc (DMAC) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bullish
SMA 200
Bullish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de DMAC, ordenadas por similitud.
Análisis de estacionalidad de DMAC
Historically the probability of a positive October return for DMAC is 93.55%. December offers the highest probability of a positive month at 100.00%, while April is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de DMAC
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Oct 2026 | $4.71 | $4.83 | $4.89 | -44.04% |
| Nov 2026 | $3.93 | $4.46 | $4.86 | -48.32% |
| Dec 2026 | $3.68 | $4.22 | $4.83 | -51.11% |
En 2026, se proyecta que DiaMedica Therapeutics Inc (DMAC) oscile entre $3.68 y $4.89.
Previsión mensual de DiaMedica Therapeutics Inc para 2026
En Oct de 2026, se proyecta que DiaMedica Therapeutics Inc promedie $4.83, con un mínimo de $4.71 y un máximo de $4.89.
En Nov de 2026, se proyecta que DiaMedica Therapeutics Inc promedie $4.46, con un mínimo de $3.93 y un máximo de $4.86.
En Dec de 2026, se proyecta que DiaMedica Therapeutics Inc promedie $4.22, con un mínimo de $3.68 y un máximo de $4.83.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.